The largest database of trusted experimental protocols

5 protocols using pmd2 g vector

1

Lentiviral Vector Cloning and Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pLK0.1 TRC cloning vector (17 (link)), the pLKO.1-TRC vector (17 (link)), and the scramble shRNA vector in pLKO.1 (18 (link)) were obtained from Addgene (Watertown, Mass). The pMD2.G vector [expressing VSV-G envelop; Addgene plasmid # 12259; http://n2t.net/addgene:12259;RRID:Addgene_12259), and psPAX2 (a lentiviral packaging vector; Addgene plasmid # 12260; http://n2t.net/addgene:12260;RRID:Addgene_12260)] were gifts from Didier Trono.
+ Open protocol
+ Expand
2

Overexpressing GPX2 in Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
A third-generation lentiviral expression system was used to overexpress YFP-tagged GPX2 and YFP, respectively, in human dermal fibroblasts. The lentiviral vectors pLV.YFP and pLV.YFP-GPX2 were kindly provided by O. Kranenburg (University Medical Center, Utrecht, the Netherlands) and co-transfected with pMDLg, pRSV-Rev, and pMD2.G vector constructs (Addgene) into HEK293 cells using jetPEI (Polyplus). Virus was harvested 2 days post-transfection. The fibroblasts were incubated with virus-containing medium for 24 hr, and infected cells were selected with 5 μg/ml puromycin 48 hr following infection.
+ Open protocol
+ Expand
3

Lentiviral Knockdown of OPA3 in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid constructs psi-LVRU6GP containing shRNA against human OPA3 were from Genecoepia (Rockville, MD, USA). The sequences of the shRNA are: 5′-GCTTCGCGCCGTAGTCTTA-3′ (shCTL), 5′-GCGAGTTCTTCAAGACCTATA-3′ (shOPA3-1), 5′-GCGAGGGCATCATCTTCATCA-3′ (shOPA3-2), and 5′-CAAGCCGCTTGCCAACCGT-3′ (shOPA3-3). To product lentiviruses, 2.8 μg of plasmid psPAX2 (Addgene, #12260), 1.6 μg of pMD2.G vector (Addgene, #12259) and 2 μg of shRNA plasmid were co-transfected into HEK293T cells (1.4 million cells) cultured in T-25 flasks using X-tremeGENE HP transfection reagent (Roche, Basel, Switzerland) according to manufacturer’s protocol. After 60 h, the medium containing viruses was collected and centrifuged for 10 min at 3000 rpm at 4 °C and then passed through a 0.45 µm filter. Cells were seeded in 6-well plate and infected with viruses and 8 µg/mL of polybrene-containing medium. Viruses were removed 24 h after infection and cells were selected with 1–2 μg/mL puromycin (Invivogen, Waltham, MA, USA) for 2 weeks. Stable transfectant cell lines were then obtained and characterized by immunoblotting for OPA3 protein levels.
+ Open protocol
+ Expand
4

Knockdown of Mouse MYO10 Using Lentiviral shRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
mCherry-Lifeact was purchased from Addgene (#54491; Cambridge, MA), and pEGFP-Myo10 was previously described5 (link). To knockdown mouse MYO10 expression, we used the pLKO.1-TRC lentiviral vector (MISSION shRNA, Sigma-Aldrich) containing shRNA against mouse MYO10 (shRNA-1;TRCN0000110606, shRNA-2;TRCN0000110608, and shRNA-3;TRCN0000379126). A non-target shRNA vector (SHC016; Sigma-Aldrich) was used as a control for the shRNA experiments. For lentiviral packaging, psPAX2 and pMD2.G vectors (Addgene plasmids #12260, #12259) were co-transfected with the pLKO.1 into HEK293T cells with X-tremeGENE HP (Sigma-Aldrich) according to the manufacturer’s instructions. Virus-containing medium was harvested 72 hrs after transfection and filtered with 0.45 μm filters (EMD Millipore, Billerica, MA). Melb-a or B16F1 cells were infected with culture supernatants from HEK293T cells at a 1:6 dilution in complete culture medium. Cells were passed after 24 hrs and selected with 4 μg/ml puromycin for 14 days.
+ Open protocol
+ Expand
5

Lentivirus-Mediated Gene Silencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the gene repression experiments, the genes were downregulated via lentivirus transfection with specific shRNAs. The lentiviral vector pLKO.1-TRC was used to construct the shRNA vectors. The DNA fragments encoding shRNAs targeting specific genes or a non-specific gene (Con shRNA) were synthesized by Genewiz (Beijing, China) and inserted into the Age I and EcoR I site of the pLKO.1-TRC vector and verified by DNA sequencing. The newly constructed lenti-shRNA vectors were subsequently co-transfected into 293TN cells (System Biosciences, Mountain View, CA) with the indicated second-generation packaging systems (psPAX2 and pMD2.G vectors, Addgene, Cambridge, MA) using Chemifect transfection reagents (Fengrui Biotechnology, Beijing, China). The lentivirus-containing supernatant was harvested after 48–72 hours of transfection and filtered through a 0.22-μm filter. Transduction was performed in the presence of 10 μg/mL polybrene for 48–72 hours, and gene knockdown efficiency was verified by western blotting. DNA sequences targeting the following specific genes were inserted into the lenti-shRNA vectors:
mouse RIP1 (5′-GCATTGTCCTTTGGGCAAT-3′), mouse RIP3 (5′-GCTGAGTTGGTAGACAAGA-3′), mouse caspase 8 (5′-GAATGGAACCTGGTATATT-3′) and mouse TRADD (5′-GCAAAGACCCTCTAAGTACCCGGAC-3′).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!